Golexanolone

N/A

Report date: 2025/11/17 10:07:52
NME

Base Information

Drug NameGolexanolone
Drug Alias NameGR-3027UC-2027
ClassificationSmall molecules > Steroids
Mechanisms of ActionGamma-aminobutyric acid A receptor antagonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSleep Apnea SyndromesHepatic EncephalopathyLiver Cirrhosis, Biliary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySerbiaItalyHungary +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUmecrine Cognition
China Registration ClassN/A

Develop Information

Active CompaniesUmecrine Cognition
Inactive CompaniesN/A
Active IndicationsSleep Apnea SyndromesHepatic EncephalopathyLiver Cirrhosis, Biliary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A